Lindbrook Capital’s Octave Specialty Group OSG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$4.8K Sell
549
-84
-13% -$885 ﹤0.01% 1969
2024
Q4
$8.01K Buy
633
+43
+7% +$518 ﹤0.01% 1771
2024
Q3
$6.61K Buy
590
+41
+7% +$479 ﹤0.01% 1885
2024
Q2
$7.04K Hold
549
﹤0.01% 1828
2024
Q1
$8.58K Hold
549
﹤0.01% 1652
2023
Q4
$9.05K Hold
549
﹤0.01% 1602
2023
Q3
$6.62K Sell
549
-68
-11% -$914 ﹤0.01% 1630
2023
Q2
$8.79K Hold
617
﹤0.01% 1542
2023
Q1
$9.55K Sell
617
-27
-4% -$437 ﹤0.01% 1482
2022
Q4
$11.2K Hold
644
﹤0.01% 1381
2022
Q3
$8K Hold
644
﹤0.01% 1398
2022
Q2
$7K Buy
644
+580
+906% +$5.51K ﹤0.01% 1384
2022
Q1
$1K Buy
64
+17
+36% +$230 ﹤0.01% 2152
2021
Q4
$1K Hold
47
﹤0.01% 1867
2021
Q3
$1K Hold
47
﹤0.01% 1664
2021
Q2
$1K Hold
47
﹤0.01% 1696
2021
Q1
$1K Hold
47
﹤0.01% 1658
2020
Q4
$1K Hold
47
﹤0.01% 1560
2020
Q3
$1K Hold
47
﹤0.01% 1498
2020
Q2
$1K Hold
47
﹤0.01% 1502
2020
Q1
$1K Buy
+47
New +$901 ﹤0.01% 1374

Other funds holding OSG

Lindbrook Capital's OSG Position: Q1 2025 in Review

Lindbrook Capital reduced its Octave Specialty Group (OSG) stake by 13% in Q1 2025, selling an estimated $885 and leaving 549 shares worth $4.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1969.

Lindbrook Capital first reported a position in OSG in Q1 2020 and has held it in 21 quarters since. The position peaked at $11.2K in Q4 2022. 175 funds tracked by Wall St. Rank hold OSG as of Q1 2025.

  • Lindbrook Capital held 549 shares of Octave Specialty Group worth $4.8K as of Q1 2025.
  • Lindbrook Capital sold 84 Octave Specialty Group shares in Q1 2025, an estimated $885.
  • Octave Specialty Group made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #1969 holding.
  • Lindbrook Capital first reported a position in Octave Specialty Group in Q1 2020 and has held it in 21 quarters since.
  • Lindbrook Capital's Octave Specialty Group position peaked at $11.2K in Q4 2022.
  • 175 funds tracked by Wall St. Rank held Octave Specialty Group as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.